Deciphera Pharmaceuticals Inc. (NASDAQ: DCPH) stock closed at 13.73 per share at the end of the most recent trading day (a -1.79% change compared to the prior day closing price) with a volume of 1.71M shares and market capitalization of 909.15M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 350 people. Deciphera Pharmaceuticals Inc. CEO is Steven L. Hoerter.

The one-year performance of Deciphera Pharmaceuticals Inc. stock is -61.11%, while year-to-date (YTD) performance is 40.53%. DCPH stock has a five-year performance of %. Its 52-week range is between 6.51 and 38.91, which gives DCPH stock a 52-week price range ratio of 22.28%

Deciphera Pharmaceuticals Inc. currently has a PE ratio of -2.40, a price-to-book (PB) ratio of 2.86, a price-to-sale (PS) ratio of 7.49, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -58.23%, a ROC of -68.32% and a ROE of -73.73%. The company’s profit margin is -%, its EBITDA margin is -281.70%, and its revenue ttm is $100.22 Million , which makes it $1.57 revenue per share.

Of the last four earnings reports from Deciphera Pharmaceuticals Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.66 for the next earnings report. Deciphera Pharmaceuticals Inc.’s next earnings report date is 02nd Aug 2022.

The consensus rating of Wall Street analysts for Deciphera Pharmaceuticals Inc. is Moderate Buy (2.4), with a target price of $16.6, which is +20.90% compared to the current price. The earnings rating for Deciphera Pharmaceuticals Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Deciphera Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Deciphera Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.18, ATR14 : 0.90, CCI20 : 200.51, Chaikin Money Flow : 0.30, MACD : 0.64, Money Flow Index : 78.56, ROC : 14.80, RSI : 64.63, STOCH (14,3) : 82.72, STOCH RSI : 0.88, UO : 67.34, Williams %R : -17.28), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Deciphera Pharmaceuticals Inc. in the last 12-months were: Daniel C. Martin (Sold 2 457 shares of value $24 465 ), Daniel Flynn (Sold 1 366 shares of value $12 362 ), Daniel L. Flynn (Sold 3 134 shares of value $31 368 ), Jama Pitman (Sold 3 590 shares of value $34 696 ), Matthew L. Sherman (Sold 5 411 shares of value $116 110 ), Thomas P. Kelly (Sold 3 136 shares of value $31 386 )